AmerisourceBergen Appoints Drug Corp. President
This article was originally published in The Pink Sheet Daily
Executive Summary
AmerisourceBergen's pharmaceutical distribution business will be headed by Terry Haas in the newly created position of AmerisourceBergen Drug Corporation president
You may also be interested in...
Bristol To Name New R&D Head Shortly
Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.
Aranesp Performance Strong Heading Into "Transition" Time, Amgen Says
The company is talking with oncologists about Aranesp ahead of a switch in Medicare reimbursement in January 2005. U.S. sales for the red blood cell product were up 32% in the third quarter.
Chiron Fluvirin Remediation Plan Design Underway
The four-pronged plan will address “bio-burden,” manufacturing techniques, quality systems and execution, CEO Pien says. Chiron has met twice with U.K. authorities and hopes to realize similar progress with FDA soon.